New Frontiers in Protein & Peptide Applied Analysis
January 9, 2014
The first professional meeting of protein & peptides analysts will bring together experts from Israel and abroad to address state of the art, as well as pragmatic and applicable, analytical issues.
| 10:30-11:10 | Homogeneous (Non-Wash) Immunoassays to Improve the Biotherapeutics Workflow | Dr. Roger Bosse Global Senior Product Leader, PerkinElmer Inc. |
| 11:10-11:35 | Role of Glycosylation in Biopharmaceutical Development and Manufacturing | Dr. Ruth Ben Yakar CEO, Procognia |
| 11:35-12:00 | Glycosylation and Functionality of Recombinant ß-Glucocerebrosidase from Various Production Systems | Dr. Yoram Tekoah Director of Glycobiology Protalix Biotherapeutics, Ltd. |
| 12:00-12:25 | Low Endotoxin Recovery in Biologics; A New FDA Perspective for Validation of IPC and Release Bacterial Endotoxin Testing | Dr. Mark Kessler Executive Director Quality Assurance, Teva Pharmaceuticals |
| 12:25-12:50 | Human Proteins Expressed in Human Cells - Superior Performance and Authentic PTMs | Dr. Nadav Askari Protein Biology (R&D) Department Head, Sigma-Aldrich Israel |
| 15:30-16:10 | Application of High Throughput Microfluidic Protein and N-Glycan Analytics in a Biotherapeutic Environment | Dr. Seth Cohen Senior Director, Discovery Applications, Life Sciences and Technology, PerkinElmer Inc. |
| 16:10-16:40 | Quantitative Proteomics: Analysis of Protein Expression and Post Translational Modifications | Dr. Yishai Levin Head of the de Botton Institute for Protein Profiling, The Nancy and Stephen Grand, Israel National Center for Personalised Medicine, Weizmann Institute of Science |
Technion – Israel Institute of Technology, Haifa, Israel
The Stephen & Nancy Grand Water Research Institute
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
